OKYO — OKYO Pharma Balance Sheet
0.000.00%
Last trade - 00:00
- $60.63m
- $61.42m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.481 | 0.19 | 4.99 | 2.06 | 3.28 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.085 | 0.263 | 0.055 | 0.672 | 0.794 |
Prepaid Expenses | |||||
Total Current Assets | 0.582 | 0.458 | 5.06 | 3.27 | 4.21 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.001 | 0.025 | 0.076 | 0.004 | 0.006 |
Total Assets | 0.583 | 0.483 | 5.14 | 3.27 | 4.21 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.327 | 0.575 | 1.24 | 1.03 | 5.88 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.327 | 0.596 | 1.28 | 1.03 | 5.88 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.255 | -0.113 | 3.85 | 2.24 | -1.66 |
Total Liabilities & Shareholders' Equity | 0.583 | 0.483 | 5.14 | 3.27 | 4.21 |
Total Common Shares Outstanding |